Logo image of PPCB

PROPANC BIOPHARMA INC (PPCB) Stock Overview

USA - NASDAQ:PPCB - US74346N7012 - Common Stock

1.52 USD
+0.04 (+2.7%)
Last: 10/24/2025, 8:00:01 PM
1.4807 USD
-0.04 (-2.59%)
After Hours: 10/24/2025, 8:00:01 PM

PPCB Key Statistics, Chart & Performance

Key Statistics
Market Cap19.47M
Revenue(TTM)N/A
Net Income(TTM)-1685600
Shares12.81M
Float4.46M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-703.62
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2012-06-15
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


PPCB short term performance overview.The bars show the price performance of PPCB in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15

PPCB long term performance overview.The bars show the price performance of PPCB in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of PPCB is 1.52 USD. In the past month the price decreased by -16.48%.

PROPANC BIOPHARMA INC / PPCB Daily stock chart

PPCB Latest News, Press Relases and Analysis

PPCB Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.53 402.76B
AMGN AMGEN INC 13.38 157.07B
GILD GILEAD SCIENCES INC 15.63 150.06B
VRTX VERTEX PHARMACEUTICALS INC 24.88 108.04B
REGN REGENERON PHARMACEUTICALS 12.66 61.26B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 60.75B
ARGX ARGENX SE - ADR 88.74 50.32B
ONC BEONE MEDICINES LTD-ADR 5.02 34.14B
INSM INSMED INC N/A 33.75B
NTRA NATERA INC N/A 26.42B
BNTX BIONTECH SE-ADR N/A 25.40B
BIIB BIOGEN INC 9.36 21.98B

About PPCB

Company Profile

PPCB logo image Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The firm has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its lead product candidate, PRP, is a variation upon its formulation and involves pro-enzymes, the inactive precursors of enzymes. PRP is a long-term therapy based on a pancreatic proenzyme formulation to prevent tumor recurrence and metastasis. PRP is a patented, formulation consisting of two proenzymes mixed in a synergetic ratio. PRP is in the preclinical phase of development. Its drug pipeline also includes POP1.

Company Info

PROPANC BIOPHARMA INC

302/6 Butler Street, Camberwell

Melbourne VICTORIA AU

Employees: 2

PPCB Company Website

PPCB Investor Relations

Phone: 61398820780

PROPANC BIOPHARMA INC / PPCB FAQ

Can you describe the business of PROPANC BIOPHARMA INC?

Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The firm has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its lead product candidate, PRP, is a variation upon its formulation and involves pro-enzymes, the inactive precursors of enzymes. PRP is a long-term therapy based on a pancreatic proenzyme formulation to prevent tumor recurrence and metastasis. PRP is a patented, formulation consisting of two proenzymes mixed in a synergetic ratio. PRP is in the preclinical phase of development. Its drug pipeline also includes POP1.


Can you provide the latest stock price for PROPANC BIOPHARMA INC?

The current stock price of PPCB is 1.52 USD. The price increased by 2.7% in the last trading session.


Does PROPANC BIOPHARMA INC pay dividends?

PPCB does not pay a dividend.


What is the ChartMill technical and fundamental rating of PPCB stock?

PPCB has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


What sector and industry does PROPANC BIOPHARMA INC belong to?

PROPANC BIOPHARMA INC (PPCB) operates in the Health Care sector and the Biotechnology industry.


What is the Short Interest ratio of PROPANC BIOPHARMA INC (PPCB) stock?

The outstanding short interest for PROPANC BIOPHARMA INC (PPCB) is 4.76% of its float.


PPCB Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to PPCB.


Chartmill TA Rating
Chartmill Setup Rating

PPCB Financial Highlights

Over the last trailing twelve months PPCB reported a non-GAAP Earnings per Share(EPS) of -703.62. The EPS increased by 98.43% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -2147.26%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%97.92%
Sales Q2Q%N/A
EPS 1Y (TTM)98.43%
Revenue 1Y (TTM)N/A

PPCB Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

PPCB Ownership

Ownership
Inst Owners9.97%
Ins Owners67.52%
Short Float %4.76%
Short Ratio1